Other studies have shown that GPC3 expression was strongly associated with clear cell ovarian carcinomas, and high GPC3-expression was significantly associated with unfavorable outcomes in cases with loss of ARID1A [76,77]. This evidence concerns the gene GPC3 and ovarian clear cell cancer.